Today: 29 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

GE Vernova stock price rises after outlook raise; traders eye Feb. 2 Prolec close

GE Vernova stock price rises after outlook raise; traders eye Feb. 2 Prolec close

GE Vernova shares closed up 1.25% at $726.37 Friday, hitting an intraday high of $752.02 before slipping 0.2% after hours. The company warned Vineyard Wind delays could cut $250 million from wind revenue and trigger $400 million in losses if 11 turbines aren’t installed. GE Vernova expects 2026 revenue of $44–$45 billion, above analyst forecasts. The Prolec GE acquisition is set to close Feb. 2.
31 January 2026
Eli Lilly stock climbs after $3.5 billion Pennsylvania plant plan as traders eye Feb. 4 results

Eli Lilly stock climbs after $3.5 billion Pennsylvania plant plan as traders eye Feb. 4 results

Eli Lilly shares rose 1.3% to $1,037.15 in after-hours trading Friday after announcing a $3.5 billion facility in Fogelsville, Pennsylvania to produce injectable weight-loss drugs, including retatrutide. Pennsylvania will contribute $100 million to the project, which is expected to create 850 permanent jobs and start operations by 2031.
ServiceNow stock: Shares stuck near $117 after earnings beat and fresh $5 billion buyback

ServiceNow stock: Shares stuck near $117 after earnings beat and fresh $5 billion buyback

ServiceNow shares rose 0.1% to $117.01 in after-hours trading Friday, after plunging 9.6% Thursday despite beating earnings forecasts and raising its 2026 subscription revenue outlook above estimates. The company’s board approved an additional $5 billion for share buybacks and announced an accelerated $2 billion repurchase. Investors remain focused on AI competition, deal integration, and sector sentiment after a broad software selloff.
Visa stock slides after hours as costs and cross-border growth overshadow earnings beat

Visa stock slides after hours as costs and cross-border growth overshadow earnings beat

Visa shares fell 3% to $321.83 in after-hours trading Friday after the company’s quarterly report showed rising expenses despite beating profit and revenue estimates. Cross-border payment volumes rose 12%, but investors focused on margin risks. American Express shares also slipped following a narrow profit miss. U.S. producer prices rose more than expected in December, while the Fed left rates unchanged.
SoFi stock slides after-hours as SOFI investors digest 2026 targets and credit-card cap talk

SoFi stock slides after-hours as SOFI investors digest 2026 targets and credit-card cap talk

SoFi Technologies shares dropped 6.4% to $22.81 in after-hours trading Friday after reporting a 37% year-over-year jump in adjusted net revenue to $1.013 billion and a 60% rise in adjusted EBITDA. The company lost a major technology client, cutting platform accounts by 23% to 128 million. CEO Anthony Noto warned that a proposed 10% credit-card rate cap could disrupt the industry.
Lam Research stock slips nearly 6% after-hours as chip-tool trade cools — what’s driving LRCX now

Lam Research stock slips nearly 6% after-hours as chip-tool trade cools — what’s driving LRCX now

Lam Research shares fell 5.9% to $233.46 in after-hours trading Friday, despite beating earnings and revenue forecasts for the quarter. The drop followed a broader sell-off in chip equipment stocks after KLA Corp’s results and a 0.94% slide in the Nasdaq. Lam reported $1.35 adjusted EPS and $5.34 billion revenue for the December quarter. China made up 35% of Lam’s revenue, down from 43% the previous quarter.
Exxon stock price rises after Q4 earnings beat; Golden Pass LNG start eyed for March

Exxon stock price rises after Q4 earnings beat; Golden Pass LNG start eyed for March

Exxon Mobil shares rose 0.7% to $141.40 in after-hours trading after posting Q4 adjusted earnings of $1.71 per share, beating estimates. The company reported $6.5 billion in earnings, announced a $1.03 per share dividend for March, and reaffirmed its $20 billion buyback plan through 2026. Upstream output hit 4.7 million boepd in 2025, with a 2026 target of 4.9 million. Refining profits rose 60% to $2.9 billion.
Seagate stock price drops nearly 9% after-hours as STX cools off — what traders watch next

Seagate stock price drops nearly 9% after-hours as STX cools off — what traders watch next

Seagate shares dropped $38.87, or 8.7%, to $407.69 in after-hours trading Friday after the company filed its quarterly report with the SEC. The stock had ranged from $397.34 to $462.98 during the session. Seagate posted fiscal Q2 revenue of $2.83 billion and adjusted earnings of $3.11 per share earlier in the week. Sandisk surged 14.7% after forecasting higher profit and revenue and extending a supply deal with Kioxia.
31 January 2026
Netflix stock price today: NFLX ticks up after hours on insider sale filing — what to watch next week

Netflix stock price today: NFLX ticks up after hours on insider sale filing — what to watch next week

Netflix shares rose 0.4% to $83.49 in after-hours trading Friday after a filing showed co-CEO Gregory Peters plans to sell up to 105,781 shares, worth about $8.77 million. The Senate Judiciary antitrust panel set a Feb. 3 hearing on Netflix’s proposed merger with Warner Bros Discovery. UK politicians urged a full probe of the deal. Paramount Skydance extended its rival offer deadline to Feb. 20.
UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth shares fell 1.8% to $286.93 in after-hours trading Friday after Barclays cut its price target. The stock has dropped about 18% since Monday, triggered by a 20% plunge Tuesday. UnitedHealth forecast 2026 revenue just over $439 billion, down 2% from last year, and signaled a medical care ratio of 88.8%. Several banks trimmed price targets this week, citing Medicare-related uncertainty.
31 January 2026
Strategy Inc (MSTR) stock rebounds after Thursday rout as bitcoin swings — what to watch next

Strategy Inc (MSTR) stock rebounds after Thursday rout as bitcoin swings — what to watch next

Strategy Inc shares closed up 4.6% at $149.71 Friday and edged higher after hours, rebounding from a 10% drop Thursday. Bitcoin steadied near $83,900 after hitting a two-month low earlier in the day. The moves followed Donald Trump’s nomination of Kevin Warsh to lead the Federal Reserve. Investors await Strategy’s fourth-quarter results on Feb. 5.
Chevron stock jumps after earnings beat, Venezuela talk takes spotlight as oil holds firm

Chevron stock jumps after earnings beat, Venezuela talk takes spotlight as oil holds firm

Chevron shares rose about 3.3% to $176.90 in after-hours trading after reporting fourth-quarter earnings of $1.52 per share, beating estimates. The company flagged possible production gains in Venezuela but warned of short-term output drops due to maintenance and disruptions. Chevron paid $12.8 billion in dividends and repurchased $12.1 billion in shares in 2025. Brent crude settled at $70.69 a barrel.
Verizon stock price jumps after earnings as $25 billion buyback lifts VZ in late trading

Verizon stock price jumps after earnings as $25 billion buyback lifts VZ in late trading

Verizon shares surged 11.8% to $44.52 in after-hours trading after the company reported 616,000 postpaid phone subscriber additions in Q4 and announced a $25 billion buyback program. Adjusted Q4 earnings reached $1.09 per share on $36.4 billion revenue. The board raised the quarterly dividend to $0.7075 per share and plans at least $3 billion in buybacks for 2026. Free cash flow for 2026 is projected at $21.5 billion or more.
Oracle stock price drops again as AI fears weigh; Air Force cloud order lands

Oracle stock price drops again as AI fears weigh; Air Force cloud order lands

Oracle shares fell 2.6% to $164.58 Friday, extending losses in software stocks despite the company winning an $88.1 million U.S. Air Force cloud contract. Investors remain cautious as concerns grow over AI-driven disruption and rising capital spending. The stock showed little movement after hours. Oracle’s next earnings report is set for March 9.
1 222 223 224 225 226 762

Stock Market Today

  • Ceres Power Surges Past Rolls-Royce, Nvidia, BP in FTSE 250 Rally
    April 29, 2026, 9:27 AM EDT. Ceres Power (LSE:CWR) leads the FTSE 250 stock gains in 2026 with a staggering 176% rise year-to-date, far outpacing Rolls-Royce, Nvidia and BP. The clean energy tech firm, specializing in licensing advanced solid oxide fuel cell and hydrogen technology, posted a remarkable 933% gain over the last year. Despite declining revenues - £32.6 million in 2025 down from £51.9 million the previous year - and no expected profits in 2026 or 2027, investor enthusiasm is fueled by the AI-driven data center boom. Its recent collaboration with Centrica aims to deploy efficient on-site power solutions swiftly for AI hubs and logistics centers. This positions Ceres as a crucial 'picks and shovels' provider amid the AI energy surge. However, over five years, the stock remains down 55%, prompting debate on its current valuation.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop